Corifollitropin alfa for poor responders patients, a prospective randomized study

Corifollitropin alfa for poor responders patients, a prospective randomized study

Abstract Background Poor ovarian response remains one of the biggest challenges for reproductive endocrinologists. The introduction of corifollitropin alpha (CFA) offered an alternative option to other gonadotropins for its longer half-life, its more rapid achievement of the threshold and higher FSH...

Full description

Bibliographic Details
Main Authors: F. M. Fusi, L. Zanga, M. Arnoldi, S. Melis, M. Cappato, I. Candeloro, A. Di Pasqua
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Reproductive Biology and Endocrinology
Subjects:
Corifollitropin alfa
Agonist
Antagonist
Poor responders
Online Access:http://link.springer.com/article/10.1186/s12958-020-00628-6

Similar Items

Similar Items